Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

European Respiratory Society statement: diagnosis and treatment of pulmonary disease in α1-antitrypsin deficiency

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Prognostic significance of chronic respiratory symptoms in individuals with normal spirometry

    Publikation: Bidrag til tidsskriftKommentar/debatForskningpeer review

  2. Budesonide/formoterol maintenance and reliever therapy in adolescent patients with asthma

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Inducible laryngeal obstruction: an official joint European Respiratory Society and European Laryngological Society statement

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Diagnostic accuracy of a clinical diagnosis of idiopathic pulmonary fibrosis: an international case-cohort study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Increased respiratory morbidity in individuals with interstitial lung abnormalities

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. The long-lasting dark shadow of past and present smoking

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. β2-Adrenergic genotypes and risk of severe exacerbations in COPD: a prospective cohort study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Tau-protein concentrations are not elevated in cerebrospinal fluid of patients with progressive multifocal leukoencephalopathy

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  5. Midlife cardiorespiratory fitness and the long-term risk of chronic obstructive pulmonary disease

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  • Marc Miravitlles
  • Asger Dirksen
  • Ilaria Ferrarotti
  • Vladimir Koblizek
  • Peter Lange
  • Ravi Mahadeva
  • Noel G McElvaney
  • David Parr
  • Eeva Piitulainen
  • Nicolas Roche
  • Jan Stolk
  • Gabriel Thabut
  • Alice Turner
  • Claus Vogelmeier
  • Robert A Stockley
Vis graf over relationer

α1-antitrypsin deficiency (AATD) is the most common hereditary disorder in adults. It is associated with an increased risk of developing pulmonary emphysema and liver disease. The pulmonary emphysema in AATD is strongly linked to smoking, but even a proportion of never-smokers develop progressive lung disease. A large proportion of individuals affected remain undiagnosed and therefore without access to appropriate care and treatment.The most recent international statement on AATD was published by the American Thoracic Society and the European Respiratory Society in 2003. Since then there has been a continuous development of novel, more accurate and less expensive genetic diagnostic methods. Furthermore, new outcome parameters have been developed and validated for use in clinical trials and a new series of observational and randomised clinical trials have provided more evidence concerning the efficacy and safety of augmentation therapy, the only specific treatment available for the pulmonary disease associated with AATD.As AATD is a rare disease, it is crucial to organise national and international registries and collect information prospectively about the natural history of the disease. Management of AATD patients must be supervised by national or regional expert centres and inequalities in access to therapies across Europe should be addressed.

OriginalsprogEngelsk
TidsskriftEuropean Respiratory Journal
Vol/bind50
Udgave nummer5
ISSN0903-1936
DOI
StatusUdgivet - 1 dec. 2017

ID: 52090501